Influence of active tuberculosis on chemokine and chemokine receptor expression in HIV-infected persons

AIDS Research and Human Retroviruses

Volumn 21, Issue 12, 2005, Pages 997-1002

  Hanna, Luke Elizabeth ^a   Bose, Jagadish Chandra ^b   Nayak, Kaustuv ^a   Subramanyam, Sudha ^a   Swaminathan, Soumya ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b MADRAS CHRISTIAN COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; MACROPHAGE INFLAMMATORY PROTEIN 1;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LUNG TUBERCULOSIS; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; VIRUS REPLICATION; AIDS RELATED COMPLEX; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; VIROLOGY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHEMOKINES; HIV INFECTIONS; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; RANTES; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; TUBERCULOSIS, PULMONARY;

EID: 30344455923     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.997     Document Type: Article

References (47)

1. Claydon EJ, Bennett J, Gor D, and Forster SM: Transient elevation of serum HIV antigen levels associated with intercurrent infection. AIDS 1991;5:113-114.
2. Denis M and Ghadirian E: Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens. Clin Exp Immunol 1994;97:76-82.
3. Goletti D, Weissman D, Jackson RW, Graham NMH, Vlahov D, Klein RS, Munsiff SS, Ortona L, Cauda R, and Fauci AS: Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996;157:1271-1278.
4. Israel-Biet D, Cadranel J, and Even P: Human immunodeficiency virus production by alveolar lymphocytes is increased during Pneumocystis carinii pneumonia. Am Rev Respir Dis 1993; 148:1306-1312.
5. Heng MC, Heng SY, and Allen SG: Co-infection and synergy of human immunodeficiency virus-1 and herpex simplex cirus-1. Lancet 1994;343:255-258.
6. Barnes PF, Bloch AB, Davidson PT, and Snider DE: Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324:1644-1650.
7. Garrait V, Cadranel J, Esvant H, Herry I, Morinet P, Mayaud C, and Israel-Biet D: Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV. J Immunol 1997;159:2824-2830.
8. Toossi Z, Hamilton BD, Phillips MH, Averill LE, Ellner JJ, and Salverkar A: Regulation of nuclear factor-κB and its inhibitor IκB-a/MAD-3 in monocytes by Mycobacterium tuberculosis and during human tuberculosis. J Immunol 1997;159:4109-4116.
9. Shapiro L, Heidenreich KA, Meintzer MK, and Dinarello CA: Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc Natl Acad Sci USA 1998;95:7422-7426.
10. Juffermans NP, Verbon A, van Deventer SJ, van Deutekom H, Belisle JT, Ellis ME, Speelman P, and can der Poll T: Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: A possible role for mycobacterial lipoarabinomannan. Infect Immun 1999;67:4295-4297.
11. Fraziano M, Cappelli G, Santucci M, Mariani F, Amicosante M, Casarini M, Giosue S, Bisetti A, and Colizzi V: Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection. AIDS Res Human Retroviruses 1999;15:869-874.
12. Mackewicz CE, Barker E, and Levy JA: Role of β-chemokines in suppressing HIV-1 replication. Science 1996;274:1393-1394.
13. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA: CC-CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science, 1996;272:1955-1958.
14. Toossi Z, Xia L, Wu M, and Salvekar A: Transcriptional activation of HIV by Mycobacterium tuberculosis in human monocytes. Clin Exp Immunol 1999;117:324-330.
15. Toossi Z, Mayanja-Kizza H, Hirsch CS, Edmonds KL, Spahlinger T, Hom DL, Aung H, Mugyenyi P, Ellner JJ, and Whalen CW: Impact of tuberculosis on HIV-1 activity in dually infected patients. Clin Exp Immunol 2000;122:1-7.
16. Nakata K, Rom WN, Honda Y, Condos R, Kanegasaki S, Cao Y, and Weiden M: Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 1997;155:996-1003.
17. Orme IM and Cooper AM: Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today 1999;20:307-312.
18. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, and Ellner J: Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151:129-135.
19. Subramanyam S, Hanna LE, Venkatesan P, Sankaran K, Narayanan PR, and Swaminathan S: HIV alters plasma and M. tuberculosis-induced cytokine production in patients with tuberculosis. J Interferon Cytokine Res 2004;24:101-106.
20. Toossi Z: Cytokine circuits in tuberculosis. Infect Agents Dis 1996;5:98-107.
21. Yao Q, Compans RW, and Chen C: HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. Virology 2001;20:128-137.
22. Cocchi F, DeVico AL, Garzino-Demo A, Cara A, Gallo RC, and Lusso P: The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat Med 1996;2:1244-1247.
23. Kelly MD, Naif HM, Adams SL, Cunningham AL, and Lloyd AR: Dichotomous effects of beta-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J Immunol 1998;160:3091-3095.
24. Bleul CC, Wu L, Hoxie JA, Springer TA, and Mackay CR: The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997;94:1925-1930.
25. Forster R, Kremmer E, Schubel A, Breitfeld D, Kleinschmidt A, Nerl C, Bernhardt G, and Lipp M: Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: Rapid internalization and recycling upon activation. J Immunol 1998;160:1522-1531.
26. Yi Y, Rana S, Turner JD, Gaddis N, and Collman RG: CXCR4 is expressed by primary macrophages and supports CCR5-independent internalization and recycling upon activation. J Virol 1998;72:772-777.
27. Tersmette M, Gruthers R, de Wolf F, de Goede R, Lange J, Schellekens P, Goudsmit J, Huismans H, and Miedma G: Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome; studies on sequential HIV isolates. J Virol 1989;63:2118-2125.
28. Richman D and Bozzette S: The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 1994;169:968-974.
29. Peeters M, Vincent R, Perret JL, Lasky M, Patrel D, Liegeois F, Courgnaud V, Seng R, Matton T, Molinier S, and Delaporte E: Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: Syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr 1999;20:115-121.
30. Bjorndal A, Sonnerborg A, Tscherning C, Albert J, and Fenyo EM: Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res Hum Retroviruses 1999;15:647-653.
31. Cecilia D, Kulkarni SS, Tripathy SP, Gangakdhekar RR, Paranjape RS, and Gadkari DA: Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 2000;271:253-258.
32. Ping LH, Nelson JA, Hoffman IF, Schock J, Lamers SL, Goodman M, Vernazza P, Kazembe P, Maida M, Zimba D, Goodenow MM, Eron JJ Jr, Fiscus SA, Cohen MS, and Swanstrom R: Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants. J Virol 1999;73:6271-6281.
33. Morris L, Cilliers T, Bredell H, Phoswa M, and Martin DJ: CCR5 is the major coreceptor used by HIV-1 subtype C isolates from patients with active tuberculosis. AIDS Res Hum Retroviruses 2001;17:697-701.
34. Ostrowski MA, Justement SJ, Cantanzaro A, Hallahan CA, Ehler LA, Mizell SB, Kumar PN, Mican JA, Chun TW, and Fauci AS: Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 1998;161:3195-3201.
35. Shalekoff S, Pendle S, Johnson D, Martin DJ, and Tiemessen CT: Distribution of the human immunodeficiency virus coreceptors CXCR4 and CCR5 on leukocytes of persons with human immunodeficiency virus type 1 infection and pulmonary tuberculosis: Implications for pathogenesis. J Clin Immunol 2001;21:390-401.
36. Giovannetti A, Ensoli F, Mazzetta F, De Cristofaro M, Pierdominici M, Muratori DS, Fiorelli V, and Aiuti F: CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy. Clin Exp Immunol 1999;118:87-94.
37. Toossi Z, Johnson JL, Kanost RA, Wu M, Luzze H, Peters P, Okwera A, Joloba M, Mugyenyi P, Mugerwa RD, Aung H, Ellner JJ, and Hirsch CS. Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: Potential mechanisms of viral activation. J Acquir Immune Defic Syndr 2001;28:1-8.
38. Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, and Ringler DJ: Cellular localization of the chemokine receptor CCR5: Correlation to cellular targets of HIV-1 infection. Am J Pathol 1997;151:1341-1351.
39. Schmidtmayerova H, Sherry B, and Bukrinsky M: Chemokines and HIV-1 replication. Nature 1996;382:767.
40. Lusso P: Chemokines and viruses: The dearest enemies. Virology 2000;273:228-240.
41. Saha K, Bentsman G, Chess L, and Volsky DJ: Endogenous production of β-chemokines by CD4+, but not CD8+ T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J Virol 1998;72:876-881.
42. Chen Y, Dampf D, Kulka K, Saha K, Chen M, and Gupta P. Differential suppression of HIV-1 by CD8+ T cells. 9th Annual Meeting of the National Cooperative Vacine Development of AIDS, 1997, p. 159.
43. Leith JG, Copeland KFT, McKay PJ, Richards CD, and Rosenthal KL: CD8+ T cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage-inflammatory protein (MIP)-1α and MIP-1β. AIDS 1997;11:575-580.
44. SF33 replication mediated by CD8+ T cell clones. AIDS 1996;10:1317-1321.
45. Moriuchi H, Moriuchi M, Combadiere C, Murphy PM, and Fauci AS: CD8+ T cell-derived soluble factors(s), but not β-chemokines RANTES, MIP-1α and MIP-1β, suppress HIV-1 replication in monocyte/macrophage. Proc Natl Acad Sci USA 1996;93: 15341-15345.
46. Kinter AL, Ostrowski M, Goletti D, Oliva A, Weissman D, Gantt K, Hardy E, Jackson R, Ehler L, and Fauci AS: HIV-1 replication in CD4+ T cells of HIV-1-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines. Proc Natl Acad Sci USA 1996;93:14076-14081.
47. Whalen CC, Nsubuga P, Okwera A, Johnson JL, Horn DL, Michael NL, Mugerwa RD, and Ellner JJ: Impact of pulmonary tuberculosis on survival of HIV-infected adults: A prospective epidemiologic study in Uganda. AIDS 2000;14:1219-1228.